Although we tested 13 of 74 patients with ovarian cancer for BRCA1 or BRCA2 mutations and found a mutation in 10 of the 13 patients with familial cancer, this result is not representative of the whole population of patients. This evidence concerns the gene BRCA1 and hereditary cancer.